1 |
Smith, R. P., A. L. Baltch, W. J. Ritz, A. N. Carpenter, T. A. Halse and L. H. Bopp. 2004. In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA. Antimicrb. Agents Chemother. 48, 2081-2084
DOI
ScienceOn
|
2 |
Suyama, N., K. Ishida, M. Kaku, K. Izumikawa and K. Hara. 1995. Therapeutic activites of macrolides against M. pneumoniae infection. Jap. J. Mycoplasmol. 21, 39-40
|
3 |
Tully, J. G. and D. L. Rose. 1979. Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly modified culture medium. J. Infect Dis. 139, 478-482
DOI
ScienceOn
|
4 |
Vester, B. and S. Douthwaite. 2001. Macrolide resistance conferred by base substitution in 23S rRNA. Antimicrob. Agents Chemother. 45, 1-12
DOI
ScienceOn
|
5 |
Waites, K. B., L. B. Duffy, T. Schmid, D. Carb, M. S. Pate and G. H. Cassell. 1991. In vitro susceptibilities of Mycoplasma pneumoniae, M. hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrobial. Agents Chemother. 35, 1181-1185
DOI
ScienceOn
|
6 |
Meloni, F., E. Paschetto, P. Mangiarotti, D. I. Crepal, M. Morosini. M. Bulgheroni and A. Fietta. 2004. Acute Chlamydia pneumniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbrations of COPD or asthma: therapeutic considerations. J. Chemother. 16(1), 70-76
|
7 |
Morozumi, M., A. Ito, S.Y. Murayama, K. Hasegawa, R. Kobayashi and K. Ubukata. 2006. Assessment of real-time PCR for diagnosis of M. pneumoniae pneumonia in pediatric patients. Can. J. Microbiol. 52(2), 125-129
DOI
ScienceOn
|
8 |
Morozumi, M., K. Hasegawa, R. Kobayashi, N. Inoue, S. Iwata, H. Kuroki, N. Kawamura, E. Nakayama, T. Tajima, K. Shimizu and K. Ubukata. 2005. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob. Agents Chemother. 49, 2302-2306
DOI
ScienceOn
|
9 |
Park, I. D., K. H. Kim, M. W. Chang and H. S. Park. 1992. Distribution of tetM gene in the tetracycline resistant Bacteria, J. Korean Soc. Microbiol. 27, 59-72
|
10 |
Pereyre, S., P. Gonzalez, B. de Barbeyrac, A. Darnige, H. Renaudin, A. Charron, S. Raherison and C. M. Bebear. 2002. Mutation in 23S rRNA account for intrinsic resistance to macrolides in M. hominis and M. fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob. Agents Chemother. 46, 3142-3150
DOI
ScienceOn
|
11 |
Pereyre, S., C. Guyot, H. Renaudin, A. Charron, C. Bebear and C. M. Bebear. 2004. In vitro selection and characterization of resistance to macrolides and related antibiotics in M. pneumoniae. Antimicrob. Agents Chemother. 48, 460-465
DOI
ScienceOn
|
12 |
Roberts, M. C., L. A. Koutsky, K. K. Holmes, D. J. LeBlanc and G. E. Kenny. 1985. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob. agents Chemother, 28, 141-143
DOI
ScienceOn
|
13 |
Duffy, L. B., D. M. Crabb, X. Bing and K. B. Waites. 2003. Bactericidal activity of levofloxacin against Mycoplasma pneumoniae. J. Antimicrob. Chemother. 52, 527-528
DOI
ScienceOn
|
14 |
Dular, R., R. Kajioka and S. Kasatiya. 1988. Comparison of gene-probe commercial kit and culture technique for the diagnosis of Mycoplasma pneumoniae infection. J. Clin. Microbiol. 26, 1068-1069
|
15 |
Ford, O. K. and J. R. Smith. 1974. Nonspecific urethritis associated with a tetracycline-resistant T-mycoplasama. Br. J. Vener. Dis. 50, 373-377
|
16 |
Kaku, M., K. Ishida, K. Irifune, R. Mizukane, H. Takemura, R. Yoshida, H. Tanaka, T. Usui, K. Tomono, N. Suyama, H. Koga, S. Kohno and K. Hara. 1994. In vitro activities of sparfloxacin against M. pneumoniae. Antimicrobil. Agents Chemother. 38, 738-741
DOI
ScienceOn
|
17 |
Kapusinik-Uner, J. E. and M. A. Sande. 1996. Chambers HF: Antimicrobial agents, tetracycline, chloramphenicol, erythromycin, and miscellaneous antimicrobial agents. pp 1123-1153, In Goodman & Gilman's The pharmacological basis of therapeutics, McGraw-Hill, New York, 9th (ed)
|
18 |
Krause, D. C. and D. Taylor-Robinson. 1992. Mycoplasma which infect humans. pp 417-444, In Maniloff J. (ed), Mycoplasmas, ASM, Washington
|
19 |
Kenny, G. E. and F. D. Cartwright. 1994. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to new glycycyclines in comparison with those to older tetracyclines. Antimicrob. Agents Chemother. 38, 2628-2632
DOI
ScienceOn
|
20 |
Kenny, G. E. and F. D. Cartwright. 1996. Susceptibilities of M. pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to new quinolone, trovafloxacin(CP-99219). Antimicrob. Agents Chemother. 40, 1048-1049
|
21 |
Matsuoka, M., M. Narita, N. Okazki, H. Ohya, T. Yamazaki, K. Ouchi, I. Suzuki, T. Andoh, T. Kenri, Y. Sasaki and T. Sasaki. 2004. Characterization and molecular analysis of macrolide-resistant M. pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48, 4624-4630
DOI
ScienceOn
|
22 |
Blanchard, A. and C. Bebear, 2002. Mycoplasmas of human, Molecular biology and pathogenicity of mycoplasma, pp 45-71, In Razin S, and Hermann R(1st ed), New York, Kluwer Academic Press, New York
|
23 |
Cassell, G. H., W. A. Clyde and J. K. Davis. 1985. The Mycoplasmas, Mycoplasmal respiratory infections, pp 65-106, Vol. IV, S. Razin and M. F. Barile (1st ed), Academic Press, New York
|
24 |
Okazaki, N., M. Narita, S. Yamada, K. Izumikawa, M. Umetsu, T. Kenri, Y. Sasaki, Y. Arakawa and T. Sasaki. 2001. Characteristics of macrolide-resistant M. pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol. Immunol. 45, 617-620
DOI
|
25 |
Chang, M. W., K. H. Kim, I. D. Park, G. Y. Song, S. W. Kim and C.E. Choi. 2005. Isolation of Mycoplasma pneumoniae and antimicrobial susceptibilities of the isolaters(III). J. Life Sci. 15, 479-485
과학기술학회마을
DOI
ScienceOn
|
26 |
Cedillo-Ramirez, L., C Gil, I. Zago, A. Yanez and S. Giono. 2000. Association of M. hominis and Ureaplasma urealyticum with some indicators of nonspecific vaginitis. Rev. Latinoam. Microbiol. 42, 1-6
|
27 |
Chang, M. W., K. H. Kim, I. D. Park and M. H. Joh. 1995. Detection of Mycoplasma pneumoniae in clinical specimens of patients by polymerase chain reaction and culture method. J. Korean Soc. Microbiol. 30, 517-525
|
28 |
Chang, M. W., K. H. Kim, I. D. Park, K. H. Kang, E. H. Kong, M. H. Joh, K. E. Kim and S.Y. Park. 2003. Rapid detection of Mycoplasma pneumoniae and antimicrobial susceptibilities of the M. pneumoniae isolates. J. Bacteriol. Virol. 33, 183-191
|
29 |
Chang, M. W., I. D. Park, K. H. Kim, G. Y. Song and S. W. Kim. 2005. Tetracycline and erythromycin resistant mutans of the Mycoplasma pneumoniae isolated from patients with reasipratory diseases. J. Life Sci. 15, 863-870
과학기술학회마을
DOI
ScienceOn
|
30 |
Arai, S., Y. Gohara, K. Kuwano and T. Kawashima. 1992. Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae. Antimicrobial Agents Chemother. 36, 1322-1324
DOI
ScienceOn
|